LoadingLoadingLoading24 funds hold it.Insiders net selling.
Net selling: insiders sold $13.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 22, 2026
Financial period
Third Quarter 2026
Earnings per share
$2.87 expected
Revenue
$3.05B expected
Full Year 2026 guidance
$12.06B to $12.11B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 22, 2026 | $3.00est. $2.87 | +4.36%beat | $3.10Best. $3.05B+1.54% | +10.0%from $2.82B |
| Jun 30, 2026Reported Jul 23, 2026 | $3.12est. $2.82 | +10.51%beat | $3.04BCompany release | +10.2%from $2.76B |
| Mar 31, 2026Reported Apr 21, 2026 | $2.50est. $2.37 | +5.61%beat | $2.90BSEC filing | +9.2%from $2.65B |
| Dec 31, 2025Reported Feb 10, 2026 | $2.42est. $2.36 | +2.63%beat | $2.81BAlpha Vantage | +7.1%from $2.62B |
| Sep 30, 2025Reported Oct 21, 2025 | $2.60est. $2.50 | +4.00%beat | $2.82BSEC filing | +13.2%from $2.49B |
| Jun 30, 2025Reported Jul 22, 2025 | $2.62est. $2.57 | +1.95%beat | $2.76BSEC filing | +15.2%from $2.40B |
| Mar 31, 2025Reported Apr 22, 2025 | $2.21est. $2.15 | +2.79%beat | $2.65BSEC filing | +12.1%from $2.37B |
| Dec 31, 2024Reported Jan 30, 2025 | $2.23est. $2.18 | +2.29%beat | $2.62BAlpha Vantage | +14.6%from $2.29B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.81B | $2.90B | $3.04B | $3.10B |
| Cost of what it sold | $1.89B | $1.95B | $2.02B | $2.06B |
| Gross profit | $914.0M | $942.0M | $1.03B | $1.04B |
| What it spent | ||||
| Sales and admin | $486.0M | $504.0M | $529.0M | $523.0M |
| Other operating costs | $37.0M | $39.0M | $39.0M | $40.0M |
| Total operating expenses | $523.0M | $543.0M | $568.0M | $563.0M |
| What was left | ||||
| Operating profit | $391.0M | $399.0M | $459.0M | $479.0M |
| Interest on debt | $67.0M | $63.0M | $63.0M | $61.0M |
| Profit before tax | $337.0M | $334.0M | $412.0M | $416.0M |
| Tax | $81.0M | $74.0M | $88.0M | $99.0M |
| Net profit | $245.0M | $252.0M | $320.0M | $312.0M |
| EBITDA | $546.0M | $544.0M | $589.0M | $624.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
MDxHealth stock faces reset as company suspends 2026 guidance
NeutralNov 5HealthSource secures financing for $60M Clermont County medical facility
Leans bullishNov 3Cardinal Health to buy AdaptHealth unit and Strive Medical for $360M
NeutralNov 3An officer proposes selling 22,105 Quest Diagnostics (DGX) shares acquired through stock options.
NeutralNov 3Waters Q3 2026 Earnings Call Transcript
Leans bullishNov 3Danaher stock draws focus to November 4 sepsis diagnostics session
NeutralNov 3A lab tool separates molecules in milliseconds. Waters acquired its maker, MOBILion.
Leans bullishNov 3Most-shorted stocks by short volume ratio - Nov 2, 2026
BearishNov 3
